# Kina reviews (2026): GLP-1 telehealth sellers | This GLP

One population, four delivery routes, and the clinical provider named with a street address.

Publisher: This GLP Editorial Team
Canonical: https://thisglp.com/reviews/kina
Updated: 2026-10-28

By [This GLP Editorial Team](https://thisglp.com/about) · Updated September 2026 Named clinic, four routes

# Kina review

One population, four delivery routes, and the clinical provider named with a street address.

## The verdict

Kina treats women in menopause and midlife and prices four GLP-1 routes on the page. Semaglutide injection is $199 a month and tirzepatide injection $249. The rate is stated to hold at every dose.

**Disclosure:** This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. [How we make money](https://thisglp.com/disclosures).

Category

GLP-1 telehealth

Molecule

Semaglutide · Tirzepatide

Form

Injection · Oral

Dose pricing

Flat across doses

Injection

From $199/mo

Oral

From $229/mo

Dose published

No

Prescription

Required

Compounded

Yes — not FDA-approved

Pharmacy

Not named

Kina is a GLP-1 program for women in menopause and midlife, and it says that is all it treats. Two molecules are offered in four forms: semaglutide by weekly injection or as a daily dissolving tablet, tirzepatide by weekly injection or as sublingual drops. Energy, sleep, hormone and NAD+ lines sit elsewhere in the catalog.

1.  ## Who writes the prescription, and what do they see?
    
    The clinical provider is named in full, which is unusual here. Services are supplied by independently licensed providers affiliated with Arora Health & Aesthetics, LLC, of 300 Lenora Street, Seattle, with a compliance contact and an outside website. A clinical lead is named as a pharmacist. Clinicians are described as menopause-trained, and review runs within twenty-four hours of intake.
    
    One five-minute questionnaire covers all four routes, and the clinician recommends which fits. Medication ships from a licensed United States pharmacy in two to three days. Dose adjustments, side-effect support and unlimited messaging are included rather than billed. Zofran for nausea is free for the first two months.
    
2.  ## What happens when the dose goes up?
    
    Kina states the price is the same at every dose, so the money question is closed. The clinical half is partly answered: dose adjustments are named as part of ongoing care, and [nausea](https://thisglp.com/research/how-long-does-nausea-last-on-a-glp1) is described as most likely in the first one to two months. No milligram is printed anywhere, so a reader cannot see where the ladder starts or ends.
    
3.  ## What the price includes
    
    Four rates are published before any intake: semaglutide injection $199, tirzepatide injection $249, tirzepatide sublingual $229, semaglutide tablet $279. A first month is $169, with $30 taken off automatically. Kina states it covers the $25 physician consultation fee rather than adding it, and charges no membership.
    
4.  ## What it claims, and what it cites
    
    All four are compounded preparations made by licensed United States pharmacies, and compounded medications are not FDA-approved. The pharmacies are called trusted and highly rated rather than being named. Kina's own FAQ explains why it charges less for [semaglutide](https://thisglp.com/research/semaglutide-cochrane-review) than [tirzepatide](https://thisglp.com/research/tirzepatide-vs-semaglutide-which-works-better), which is an honest way to frame a price gap.
    

## Where it holds up, and where it does not

-   Strength: The medical group is named with a street address
-   Strength: Four delivery routes priced before the intake
-   Strength: The $25 consult fee is covered, not added
-   Strength: Anti-nausea medication included for two months
-   Strength: Same price stated at every dose
-   Limitation: No milligram appears beside any of the four rates
-   Limitation: The compounding pharmacies are not named
-   Limitation: No state coverage list is published
-   Limitation: The $169 opening rate lasts one month

## What the evidence says about this kind of treatment

The assessment above is about Kina. These are about the drugs it sells, and they are traced to the primary literature.

-   [What happens to the dose, and to the side effects, over the first twenty weeks?](https://thisglp.com/research/how-long-does-nausea-last-on-a-glp1)
-   [How much of the weight lost is muscle, and what changes that?](https://thisglp.com/research/muscle-loss-on-glp1)
-   [What does the trial evidence show when treatment stops?](https://thisglp.com/research/stopping-glp1-and-weight-regain)

Right for

A woman in menopause who wants the prescribing group named and four routes priced.

Wrong for

A buyer who needs to know the milligrams behind each rate before choosing.

## The evidence behind what Kina prescribes

These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation.

-   [Cochrane Review of Semaglutide for Obesity: 18 Trials Graded](https://thisglp.com/research/semaglutide-cochrane-review)
    
    A 2025 Cochrane review pooled eighteen randomized trials. The weight figure is high certainty and smaller than the marketing, and almost everything else is graded lower.
    
-   [Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?](https://thisglp.com/research/tirzepatide-vs-semaglutide-which-works-better)
    
    In a 72-week randomized trial at weight-management doses, weight fell 20.2 percent on tirzepatide and 13.7 percent on semaglutide. Routine-care studies found a smaller gap, three to four points.
    

## How Kina compares

| Seller | Who it suits | Go |
| --- | --- | --- |
| Tuyo Health | Buyers weighing a compounded plan against brand Wegovy or Zepbound at the same clinic |  |
| Mochi Health | Buyers who want the dose ladder priced in milligrams before they commit |  |
| T2D.com | Buyers who already hold a GLP-1 prescription and want a dose-labeled cash rate |  |

[Compare all providers side by side →](https://thisglp.com/best)

More GLP-1 telehealth sellers reviews: [Neo Soma Healthcare](https://thisglp.com/reviews/neo-soma-healthcare) [NEUVÉ Health](https://thisglp.com/reviews/neuve-md) [New Wave Health](https://thisglp.com/reviews/new-wave-health) [NewSelf](https://thisglp.com/reviews/newself) [Nex Gen Health Rx](https://thisglp.com/reviews/nex-gen-health-rx) [NexLife](https://thisglp.com/reviews/nexlife)

Sponsored alternative

SkinnyRx

Readers choosing tirzepatide, the one line with a published standing rate

## Frequently asked

Who actually writes the prescription?

Independently licensed providers affiliated with Arora Health & Aesthetics, LLC, of Seattle, which Kina names in its own FAQ.

Is the consultation fee extra?

No. Kina states the $25 physician consultation fee is covered rather than added to the monthly rate.

Does the price go up as the dose goes up?

Kina states the price is the same at every dose, with no surprise increases.

Is Kina expensive compared with other GLP-1 telehealth sellers?

Kina publishes a starting figure of $199/mo. Across the 402 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $49 to $525.42 with a median of $190, which puts Kina above the median. The other 178 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.

Or [compare every seller we cover](https://thisglp.com/best).

**Research, not medical advice.** This GLP is independent and educational. Nothing here is a substitute for individualized care from a licensed clinician, and reading it creates no doctor–patient relationship. Talk to your own provider before starting, stopping, or changing any medication, peptide, or therapy. See our [methodology](https://thisglp.com/methodology) and [terms](https://thisglp.com/terms).
